表纸
市场调查报告书
商品编码
1027061

人体微生物的全球市场 - 产业分析,市场规模,占有率,成长率,趋势,预测:2020年~2027年

Global Human Microbiome Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2020 to 2027

出版日期: | 出版商: Value Market Research | 英文 210 Pages | 商品交期: 最快1-2个工作天内

价格
  • 全貌
  • 简介
  • 目录
简介

全球人体微生物市场在过去几年中达到显著增长,预计在2021年~2027年的预测期间内将大幅成长。

本报告提供全球人体微生物市场相关调查分析,提供推动市场要素·阻碍因素·课题·机会,加上收益相关市场发展相关的系统性资讯。

目录

第1章 序文

第2章 摘要整理

第3章 人体微生物:产业分析

  • 简介:市场动态
  • 推动市场要素
  • 阻碍市场要素
  • 机会
  • 产业趋势
  • 波特的五力分析
  • 市场魅力分析

第4章 价值链分析

  • 价值链分析
  • 原料分析
  • 潜在的买主清单
  • 行销流通管道

第5章 COVID-19疫情的影响分析

  • COVID-19疫情的影响分析
  • COVID-19的影响分析:生产·进口·出口·各需求
  • 市场:COVID-19前 vs. COVID-19后
  • COVID-19COVID-19疫情的影响评估
  • COVID-19:微觀/宏觀要素分析

第6章 全球人体微生物市场分析:各产品

  • 概要:各产品
  • 实际成果资料与预测资料
  • 分析:各产品
  • 益生菌
  • 益生元
  • 诊断检验
  • 医药品
  • 其他

第7章 全球人体微生物市场分析:各疾病

  • 概要:各疾病
  • 实际成果资料与预测资料
  • 分析:各疾病
  • 感染疾病
  • 内分泌·代谢障碍
  • 肠胃疾病
  • 癌症
  • 其他

第8章 全球人体微生物市场分析:各用途

  • 概要:各用途
  • 实际成果资料与预测资料
  • 分析:各用途
  • 治疗
  • 诊断

第9章 全球人体微生物市场分析:各技术

  • 概要:各技术
  • 实际成果资料与预测资料
  • 分析:各技术
  • 基因学
  • 蛋白质体学
  • 代谢体学

第10章 全球人体微生物市场分析:各地区

  • 各地区的预测
  • 简介
  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东·非洲

第11章 人体微生物企业的竞争情形

  • 人体微生物市场竞争
  • 伙伴关系/合作/契约
  • M&A
  • 新产品销售
  • 其他的发展

第12章 企业简介

  • 企业占有率分析
  • 市场集中度
  • Embion Technologies SA
  • ENTEROME SA
  • Evelo Biosciences Inc.
  • IGEN BIOLAB GROUP
  • 4D Pharma Plc.
  • Ferring Pharmaceuticals
  • Gnubiotics Sciences
  • YSOPIA Bioscience
  • ViThera Pharmaceuticals Inc.
  • Gnubiotics Sciences
  • Osel Inc.
  • SECOND GENOME THERAPEUTICS
  • Immuron Ltd.
  • OxThera AB
  • AOBiome
  • Vedanta Biosciences Inc.
目录
Product Code: VMR11215790

Value Market Research's latest report on the Global Human Microbiome Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2021-2027.

The global human microbiome market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global human microbiome market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global human microbiome market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global human microbiome market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global human microbiome market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global human microbiome market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global human microbiome market.

The market analysis involves a section exclusively to list the major players of the global human microbiome market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Human Microbiome Market Report Segments the market as below:

By Product

  • Probiotics
  • Prebiotics
  • Diagnostic Tests
  • Drugs
  • Other Products

By Disease

  • Infectious Diseases
  • Endocrine and Metabolic Disorders
  • Gastrointestinal Diseases
  • Cancer
  • Other Diseases (Cardiovascular Diseases, Neurological Disorders, Dermatology Diseases, Immune-Modulated Disorders, and Hematological Disorders.)

By Application

  • Therapeutics
  • Diagnostics

By Technology Type

  • Genomics
  • Sequencing
    • 16s rRNA sequencing method
    • Whole-genome sequencing method
    • Other Sequencing methods (shotgun metagenomic sequencing, transcriptomics, and targeted sequencing.)
  • Other Genomic Technologies (Polymerase Chain Reaction (PCR), Fluorescence In Situ Hybridization (FISH), and DNA Microarrays)
    • Proteomics
    • Metabolomics

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . HUMAN MICROBIOME - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Product
    • 3.7.2 By Disease
    • 3.7.3 By Application
    • 3.7.4 By Technology
    • 3.7.5 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Probiotics Market by Regions
  • 6.5 Prebiotics Market by Regions
  • 6.6 Diagnostic Tests Market by Regions
  • 6.7 Drugs Market by Regions
  • 6.8 Other Products Market by Regions

7 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY DISEASE

  • 7.1 Overview by Disease
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Disease
  • 7.4 Infectious Diseases Market by Regions
  • 7.5 Endocrine and Metabolic Disorders Market by Regions
  • 7.6 Gastrointestinal Diseases Market by Regions
  • 7.7 Cancer Market by Regions
  • 7.8 Other Diseases Market by Regions

8 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Therapeutics Market by Regions
  • 8.5 Diagnostics Market by Regions

9 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY TECHNOLOGY

  • 9.1 Overview by Technology
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Technology
  • 9.4 Genomics Market by Regions
  • 9.5 Proteomics Market by Regions
  • 9.6 Metabolomics Market by Regions

10 . GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America
    • 10.3.1. Overview, Historic and Forecast Data
    • 10.3.2. North America By Segment
    • 10.3.3. North America By Country
    • 10.3.4. United State
    • 10.3.5. Canada
    • 10.3.6. Mexico
  • 10.4. Europe
    • 10.4.1. Overview, Historic and Forecast Data
    • 10.4.2. Europe by Segment
    • 10.4.3. Europe by Country
    • 10.4.4. United Kingdom
    • 10.4.5. France
    • 10.4.6. Germany
    • 10.4.7. Italy
    • 10.4.8. Russia
    • 10.4.9. Rest Of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Overview, Historic and Forecast Data
    • 10.5.2. Asia Pacific by Segment
    • 10.5.3. Asia Pacific by Country
    • 10.5.4. China
    • 10.5.5. India
    • 10.5.6. Japan
    • 10.5.7. South Korea
    • 10.5.8. Australia
    • 10.5.9. Rest Of Asia Pacific
  • 10.6. Latin America
    • 10.6.1. Overview, Historic and Forecast Data
    • 10.6.2. Latin America by Segment
    • 10.6.3. Latin America by Country
    • 10.6.4. Brazil
    • 10.6.5. Argentina
    • 10.6.6. Peru
    • 10.6.7. Chile
    • 10.6.8. Rest of Latin America
  • 10.7. Middle East & Africa
    • 10.7.1. Overview, Historic and Forecast Data
    • 10.7.2. Middle East & Africa by Segment
    • 10.7.3. Middle East & Africa by Country
    • 10.7.4. Saudi Arabia
    • 10.7.5. UAE
    • 10.7.6. Israel
    • 10.7.7. South Africa
    • 10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE HUMAN MICROBIOME COMPANIES

  • 11.1. Human Microbiome Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF HUMAN MICROBIOME INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Embion Technologies S.A
    • 12.3.1. Company Overview
    • 12.3.2. Financials
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. ENTEROME SA
    • 12.4.1. Company Overview
    • 12.4.2. Financials
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Evelo Biosciences Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financials
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. IGEN BIOLAB GROUP
    • 12.6.1. Company Overview
    • 12.6.2. Financials
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. 4D Pharma Plc.
    • 12.7.1. Company Overview
    • 12.7.2. Financials
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Ferring Pharmaceuticals
    • 12.8.1. Company Overview
    • 12.8.2. Financials
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Gnubiotics Sciences
    • 12.9.1. Company Overview
    • 12.9.2. Financials
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. YSOPIA Bioscience
    • 12.10.1. Company Overview
    • 12.10.2. Financials
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. ViThera Pharmaceuticals Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Financials
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Gnubiotics Sciences
    • 12.12.1. Company Overview
    • 12.12.2. Financials
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Osel Inc.
    • 12.13.1. Company Overview
    • 12.13.2. Financials
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. SECOND GENOME THERAPEUTICS
    • 12.14.1. Company Overview
    • 12.14.2. Financials
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Immuron Ltd.
    • 12.15.1. Company Overview
    • 12.15.2. Financials
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. OxThera AB
    • 12.16.1. Company Overview
    • 12.16.2. Financials
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. AOBiome
    • 12.17.1. Company Overview
    • 12.17.2. Financials
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. Vedanta Biosciences Inc.
    • 12.18.1. Company Overview
    • 12.18.2. Financials
    • 12.18.3. Products
    • 12.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product (USD MN)
  • Probiotics Market by Geography (USD MN)
  • Prebiotics Market by Geography (USD MN)
  • Diagnostic Tests Market by Geography (USD MN)
  • Drugs Market by Geography (USD MN)
  • Other Products Market by Geography (USD MN)
  • Analysis Market by Disease (USD MN)
  • Infectious Diseases Market by Geography (USD MN)
  • Endocrine and Metabolic Disorders Market by Geography (USD MN)
  • Gastrointestinal Diseases Market by Geography (USD MN)
  • Cancer Market by Geography (USD MN)
  • Other Diseases Market by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Therapeutics Market by Geography (USD MN)
  • Diagnostics Market by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Genomics Market by Geography (USD MN)
  • Proteomics Market by Geography (USD MN)
  • Metabolomics Market by Geography (USD MN)
  • Global Human Microbiome Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Human Microbiome Report
  • Market Research Process
  • Market Research Methodology
  • Global Human Microbiome Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Disease
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Probiotics Market by Geography (USD MN)
  • Prebiotics Market by Geography (USD MN)
  • Diagnostic Tests Market by Geography (USD MN)
  • Drugs Market by Geography (USD MN)
  • Other Products Market by Geography (USD MN)
  • Global Market Analysis by Disease (USD MN)
  • Infectious Diseases Market by Geography (USD MN)
  • Endocrine and Metabolic Disorders Market by Geography (USD MN)
  • Gastrointestinal Diseases Market by Geography (USD MN)
  • Cancer Market by Geography (USD MN)
  • Other Diseases Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Therapeutics Market by Geography (USD MN)
  • Diagnostics Market by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Genomics Market by Geography (USD MN)
  • Proteomics Market by Geography (USD MN)
  • Metabolomics Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.